Cytek BioSciences Inc (CTKB): Next-Year EPS Estimate 48.96%
As of 2026-05-13, Cytek BioSciences Inc (CTKB) has a next-year EPS growth estimate of 48.96%.
On 2026-05-13, analyst consensus for CTKB's next-year EPS growth shifted from 47.83% to 48.96% — a positive change of 1.13 percentage points. Current-year growth is projected at 53.85%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 48.96%
- EPS growth this year
- 53.85%
- EPS next quarter (est)
- -$0.05
- Last price
- $3.95
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-13 | 48.96% | 53.85% | -$0.05 | $3.95 |
| 2026-05-12 | 47.83% | 55.77% | -$0.05 | $4.04 |
| 2026-05-11 | 39.60% | 51.44% | -$0.06 | $4.12 |
| 2026-05-10 | 39.60% | 51.44% | -$0.06 | $4.61 |
| 2026-05-07 | 31.33% | 60.10% | -$0.09 | $4.92 |
| 2026-05-06 | 31.33% | 60.10% | -$0.09 | $4.94 |
| 2026-05-05 | 31.33% | 60.10% | -$0.09 | $4.78 |
| 2026-05-04 | 31.33% | 60.10% | -$0.09 | $4.66 |
| 2026-05-03 | 31.33% | 60.10% | -$0.09 | $4.62 |
| 2026-04-30 | 31.33% | 60.10% | -$0.09 | $4.56 |
| 2026-04-29 | 31.33% | 60.10% | -$0.09 | $4.44 |
| 2026-04-28 | 31.33% | 60.10% | -$0.09 | $4.57 |
| 2026-04-27 | 31.33% | 60.10% | -$0.09 | $4.46 |
| 2026-04-26 | 31.33% | 60.10% | -$0.09 | $4.40 |
| 2026-04-24 | 31.33% | 60.10% | -$0.09 | $4.40 |
| 2026-04-23 | 31.33% | 60.10% | -$0.09 | $4.26 |
| 2026-04-22 | 31.33% | 60.10% | -$0.09 | $4.65 |
| 2026-04-21 | 31.33% | 60.10% | -$0.09 | $4.63 |
| 2026-04-20 | 31.43% | 59.62% | -$0.09 | $4.57 |
| 2026-04-19 | 31.43% | 59.62% | -$0.09 | $4.61 |
| 2026-04-16 | 31.43% | 59.62% | -$0.09 | $4.61 |
| 2026-04-15 | 31.43% | 59.62% | -$0.09 | $4.69 |
| 2026-04-14 | 31.43% | 59.62% | -$0.09 | $4.62 |
| 2026-04-13 | 31.43% | 59.62% | -$0.09 | $4.59 |
| 2026-04-12 | 31.43% | 59.62% | -$0.10 | $4.53 |
| 2026-04-10 | 31.43% | 59.62% | -$0.10 | $4.45 |
| 2026-04-09 | 31.43% | 59.62% | -$0.10 | $4.62 |
| 2026-04-08 | 31.43% | N/A | -$0.10 | $4.66 |
| 2026-04-07 | 31.43% | N/A | -$0.10 | $4.60 |
| 2026-04-06 | 31.43% | N/A | -$0.10 | $4.60 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Cytek BioSciences Inc's next-year EPS growth estimate?▾
As of 2026-05-13, Cytek BioSciences Inc (CTKB) has a next-year EPS growth estimate of 48.96%, based on analyst consensus.
When was the latest EPS estimate revision for CTKB?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 47.83% to 48.96%.
What sector and industry does Cytek BioSciences Inc belong to?▾
Cytek BioSciences Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CTKB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Cytek BioSciences Inc (CTKB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports